Abstract
ObjectiveTo investigate whether concomitant Alzheimer's disease (AD) pathology, reflected by cerebrospinal fluid (CSF) biomarkers, has an impact on dementia with Lewy bodies (DLB) in terms of clinical presentation, cognitive decline,...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have